Mild cognitive impairment and neuropsychological examination

Erik Hessen1

  • 1Department of Neurology, Akershus University Hospital and Department of Psychology, University of Oslo, Oslo, Norway.

Frontiers in Psychology
|December 10, 2025
PubMed
Abstract

Insights

Early diagnosis of mild cognitive impairment (MCI) is crucial. Comprehensive neuropsychological assessment is recommended for accurate diagnosis and prognosis of MCI, aiding in prevention and treatment.

Area of Science:

  • Neurology
  • Neuropsychology
  • Geriatrics

Background:

  • Mild cognitive impairment (MCI) affects cognitive function beyond normal aging and is a risk factor for dementia.
  • MCI can stem from treatable medical or psychological causes, necessitating early identification.
  • Timely diagnosis allows for interventions to prevent further decline or manage underlying conditions.

Purpose of the Study:

  • To review diagnostic systems and algorithms for MCI.
  • To highlight the role of neuropsychological assessment in diagnosing MCI.
  • To discuss key factors in MCI diagnosis and management.

Main Methods:

  • Focus on internationally prevailing diagnostic systems and algorithms for MCI.
  • Emphasis on the role of neuropsychological assessment in MCI diagnosis.
  • Consideration of cognitive domains, relevant tests, norms, and cut-off scores.

Main Results:

  • Neuropsychological assessment is key to diagnosing MCI.
  • Discussion covers relevant cognitive domains, tests, norms, and cut-off scores for sensitivity and specificity.
  • Findings guide conclusions and recommendations for neuropsychological evaluations.

Conclusions:

  • Comprehensive neuropsychological assessment is recommended best practice for MCI.
  • Utilizing multiple tests across five cognitive domains (memory, attention, language, visuospatial, executive function) is advised.
  • Employing national and culturally adapted norms enhances validity for neuropathology and prognosis.

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
512
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
745
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
486